Impairments in the capacity of dopaminergic neurons to handle cytoplasmic dopamine may be a critical factor underlying the selective vulnerability of midbrain dopamine neurons in Parkinson's disease. Furthermore, toxicity of α-synuclein in dopaminergic neurons has been suggested to be mediated by direct interaction between dopamine and α-synuclein through formation of abnormal α-synuclein species, although direct in vivo evidence to support this hypothesis is lacking. Here, we investigated the role of dopamine availability on α-synuclein mediated neurodegeneration in vivo. We found that overexpression of α-synuclein in nigral dopamine neurons in mice with deficient vesicular storage of dopamine led to a significant increase in dopaminergic neurodegeneration. Importantly, silencing the tyrosine hydroxylase enzyme -thereby reducing dopamine content in the nigral neurons -reversed the increased vulnerability back to the baseline level observed in wild-type littermates, but failed to eliminate it completely. Importantly, TH knockdown was not effective in altering the toxicity in the wild-type animals. Taken together, our data suggest that under normal circumstances, in healthy dopamine neurons, cytoplasmic dopamine is tightly controlled such that it does not contribute significantly to α-synuclein mediated toxicity. Dysregulation of the dopamine machinery in the substantia nigra, on the other hand, could act as a trigger for induction of increased toxicity in these neurons and could explain how these neurons become more vulnerable and die in the disease process.
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting the central nervous system. It is characterized by tremor, bradykinesia, rigidity, gait and postural instability and a variety of non-motor symptoms such as cognitive impairments. The pathological hallmark of PD involves degeneration of dopaminergic (DAergic) neurons predominantly in the substantia nigra (SN). A small fraction of PD cases present themselves with a family history, whereas majority of the patients suffer from the sporadic form of the disease. Both duplications and triplications of the wild-type α-synuclein (α-syn) gene have been found to cause familial PD (Chartier-Harlin et al., 2004; Singleton et al., 2003) . Furthermore, α-syn was discovered as a major component of Lewy bodies -cytoplasmic inclusions that are found in surviving cells -in post mortem analysis of PD brains (Spillantini et al., 1997) . The involvement of α-syn in both sporadic and familial forms of PD generated an interest to investigate whether an interaction between α-syn and DA was in the culprit of neurodegeneration in PD.
Overexpression of α-syn in vitro leads to DAergic cell death that can be abolished by inhibition of DA synthesis and partially blocked by antioxidants (Xu et al., 2002; Zhou et al., 2002) , suggesting that α-syn toxicity is dependent on availability of DA and mediated by oxidative stress (Chesselet, 2003; Maguire-Zeiss et al., 2005) . Indeed, the significance of oxidative stress in the pathogenesis of PD is widely accepted. The degradation of DA in the cytoplasm is a source for oxidative stress as DA undergoes auto-oxidation generating H 2 O 2 , DA-quinones and other oxidation products that could interact with α-syn promoting oligomerization (Galvin, 2006; Jenner, 2003; Maguire-Zeiss et al., 2005) . Moreover, α-syn interacts with various key proteins of the DAergic system, pointing to a role for α-syn in normal DAergic function (Perez and Hastings, 2004; Sidhu et al., 2004) . Indeed α-syn has been shown to modulate the activity or bioavailability of tyrosine hydroxylase (TH), DA transporter (DAT) and vesicular monoamine transporter-2 (VMAT2) function, aromatic amino acid decarboxylase and tetrahydrobiopterin (co-factor essential for TH function) (Baptista et al., 2003; Lee et al., 2001; Peng et al., 2005; Perez et al., 2002; Tehranian et al., 2006) . Impairments in the capacity to handle cellular stress could cause dysregulation of the cellular machinery controlling cytosolic DA levels, which could in turn trigger a cascade of events involving α-syn and lead to neurodegeneration. Recent studies have shown that increased cytosolic DA levels achieved by incubation of slice preparations in high L-DOPA containing medium resulted in increased toxicity, which was dependent on the presence of α-syn in these cells (Mosharov Neurobiology of Disease 47 (2012) 367-377 
